Tag Archive: Berthiaume Institute for Precision Health

May 09

AY 2026 in Review: PD[N]ano Lab Highlights Featured in the Provost’s TPAC-RL May 2026 Newsletter

The Provost’s TPAC-RL Faculty Newsletter (Spring 2026) went out this week, and I’m grateful that several of the lab’s milestones from the past academic year were included in the round-up of faculty achievements. The newsletter is sent to the university’s Teaching, Professor of the Practice, Advising, Clinical, Research, and Library faculty community, and it’s a …

Continue reading »

May 09

Aurelie Brownsberger Leads a Student Cohort in a Journal of Nanotheranostics Invited Feature Review on Intrinsically Selective Therapeutic Nanoplatforms

I am thrilled to share that our invited Feature Review — led by graduate researcher Aurelie Brownsberger as lead author with significant contributions from undergraduate researchers in our group— is now published in MDPI’s Journal of Nanotheranostics (JNT), as part of the Special Issue: Feature Review Papers in Nanotheranostics. Title: Intrinsically Selective Nanoplatforms for Precision …

Continue reading »

Apr 24

Pitching MagSiNs at the IDEA Center’s Inaugural Research Commercialization Grant Event

On Friday, April 24, 2026, I had the privilege of being one of six Notre Dame faculty selected to pitch at the inaugural Research Commercialization Grant (RCG) Pitch Event, hosted by the IDEA Center at Notre Dame in Leighton Hall at Innovation Park. The morning brought together external investors, the IDEA Center Advisory Council, and …

Continue reading »

Apr 20

From the Bench to the Big Picture: Kendall Bradley Earns ACS Honors at the 2026 Hoosier Science and Engineering State Fair and Returns to the Lab for Senior Year!

A few weeks ago, I shared the news of Kendall Bradley’s outstanding performance at the Northern Indiana Regional Science and Engineering Fair (NIRSEF). I am thrilled to follow up with another reason to celebrate. At the Hoosier Science and Engineering Fair / Indiana State Science Fair, Kendall earned the 2nd Place Award from the American …

Continue reading »

Mar 23

Aurelie Brownsberger Selected for Oral Presentation and Travel Award at the 14th Annual Harper Cancer Research Day

I am thrilled to share that Aurelie Brownsberger, a graduate researcher working on a PD[N]ano Lab project, was selected for an oral presentation at the 14th Annual Harper Cancer Research Day, held on Monday, March 23, 2026 at the University of Notre Dame. This is a meaningful distinction. Of the more than 100 abstracts submitted …

Continue reading »

Mar 17

It’s Official: U.S. Patent No. 12,576,160 Issued for Our Bispecific Bridge Nanoparticle Technology

I am delighted to share that on March 17, 2026, the United States Patent and Trademark Office officially issued U.S. Patent No. 12,576,160 for our technology, “Bispecific bridge nanoparticles for efficient targeting of cancer cells using immunotherapy (universal CAR-T cells) or chemotherapeutic” (Notre Dame docket P21-043-US01). This is the same invention that received its Notice …

Continue reading »

Mar 10

A Busy Week in Raleigh: TechConnect World 2026 — Two Chaired Sessions, Two Oral Talks, and a BactiBlank Finalist Pitch

I had the privilege of representing the PD[N]ano Lab and the Berthiaume Institute for Precision Health at the 29th Annual TechConnect World Innovation Conference and Expo, held March 10–12, 2026 at the Raleigh Convention Center and the Raleigh Marriott City Center in Raleigh, North Carolina. It was a packed three days — between chairing sessions, …

Continue reading »

Mar 04

Celebrating Excellence: Kendall Bradley Shines at NIRSEF 2026!

I am incredibly proud to announce the outstanding achievements of our student researcher, Kendall Bradley, a junior at Marian High School. At the recent Northern Indiana Regional Science and Engineering Fair (NIRSEF) (Feb 28, 2026), Kendall’s hard work, analytical rigor, and dedication paid off in a big way. She took home a 2nd Place Ribbon, …

Continue reading »

Jan 19

Our Lab at Notre Dame Receives Notice of Patent Allowance for Novel Nanoparticle Immunotherapy Technology

The patent office has officially issued a Notice of Allowance for Application US 18/547,664, marking a significant step forward in the fight against cancer. The technology, developed by Prakash Nallathamby and the research team, introduces a novel approach utilizing “Bispecific bridge nanoparticles.” Bridging the Gap in Cancer Treatment Current challenges in cancer therapy often revolve …

Continue reading »

Aug 30

Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL)

Dr. Nallathamby presented on his abiotic biomimicking antibacterial Nanoparticles, and how they were successfully tested against  A. baumannii BA1605 S.aureus USA300, P.aeruginosa FRD1, K. pneumoniae, C.striatum, E. faecalis, and S. pyogenes. We saw little to no evolution of resistance at doses above the MIC. Additionally, we observed what looks like inflammation-free wound healing in mouse and rat models. The wound size stabilizes as soon as the formulation is …

Continue reading »

Older posts «